Purevax Rcp 1 dose of 1 mL or 0.5 mL contains Attenuated feline rhinotracheitis herpesvirus(FHV F2 strain)≥104.9 CCID50; Inactivated feline calicivirus (FCV 431 and FCV G1 strains) antigens≥ 2.0 ELISA U.; Attenuated feline panleucopenia virus (PLI IV) ≥103.5 CCID50 Suspension For Injection (Sc) Philippines - English - FDA (Food And Drug Administration)

purevax rcp 1 dose of 1 ml or 0.5 ml contains attenuated feline rhinotracheitis herpesvirus(fhv f2 strain)≥104.9 ccid50; inactivated feline calicivirus (fcv 431 and fcv g1 strains) antigens≥ 2.0 elisa u.; attenuated feline panleucopenia virus (pli iv) ≥103.5 ccid50 suspension for injection (sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), panleucopenia virus (pli iv) and inactivated calicivirus (fcv 431) and (fcv g1 strains) - suspension for injection (sc) - 1 dose of 1 ml or 0.5 ml contains attenuated feline rhinotracheitis herpesvirus(fhv f2 strain)≥104.9 ccid50; inactivated feline calicivirus (fcv 431 and fcv g1 strains) antigens≥ 2.0 elisa u.; attenuated feline panleucopenia virus (pli iv) ≥103.5 ccid50

Biofel PCH Formulation:   Each dose (1 mL) contains:   Inactivated Feline Panleukopenia (FP) Virus (FPV-Bio 7 strain) .......... <10^3 TCID50 Feline Calicivirus (FCV) (FCV-Bio 8 strain) ...............< 10^5.5 TCIDO Feline Herpesvirus (FHV) (FHV-1-Bio 9)........<10% TCID50 TCID - Median Tissue Culture Infectious Dose Emulsion for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biofel pch formulation: each dose (1 ml) contains: inactivated feline panleukopenia (fp) virus (fpv-bio 7 strain) .......... <10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ...............< 10^5.5 tcido feline herpesvirus (fhv) (fhv-1-bio 9)........<10% tcid50 tcid - median tissue culture infectious dose emulsion for injection (sc)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) vaccine (vet.) - emulsion for injection (sc) - formulation: each dose (1 ml) contains: inactivated feline panleukopenia (fp) virus (fpv-bio 7 strain) .......... <10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ...............< 10^5.5 tcido feline herpesvirus (fhv) (fhv-1-bio 9)........<10% tcid50 tcid - median tissue culture infectious dose

Biofel PCHR : Formulation:   Each mL (dose) contains:   Inactivated Feline Panleukopenia Virus (FPV) (FPV-Bio 7 strain) ....... > 10^3 TCID50 Feline Calicivirus (FCV) (FCV-Bio 8 strain) ............. > 10^5.5 TCID 50 Feline Herpesvirus (FHV) (FHV-1-Bio 8).............. > 10^5 TCID 50 Rabies Virus (MSV Bio 16-Vnukovo-32 strain)........... >.1 IU TCID - Tissue Culture Infectious Dose IU - International Unit Emulsion for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biofel pchr : formulation: each ml (dose) contains: inactivated feline panleukopenia virus (fpv) (fpv-bio 7 strain) ....... > 10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ............. > 10^5.5 tcid 50 feline herpesvirus (fhv) (fhv-1-bio 8).............. > 10^5 tcid 50 rabies virus (msv bio 16-vnukovo-32 strain)........... >.1 iu tcid - tissue culture infectious dose iu - international unit emulsion for injection (sc)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) , rabies virus (rv) vaccine (vet.) - emulsion for injection (sc) - : formulation: each ml (dose) contains: inactivated feline panleukopenia virus (fpv) (fpv-bio 7 strain) ....... > 10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ............. > 10^5.5 tcid 50 feline herpesvirus (fhv) (fhv-1-bio 8).............. > 10^5 tcid 50 rabies virus (msv bio 16-vnukovo-32 strain)........... >.1 iu tcid - tissue culture infectious dose iu - international unit

Nobilis® Rismavac + CA126 Formulation:   Each dose contains:   Turkey Herpes Virus (THV) Serotype 3 (FC-126 Strain)....... Chicken Herpes Virus (CHV) Serotype 1 (CVI-988 Strain)   PFU-Plaque Forming Units   Processed under FDA-2021-001.   ..3 logi PFU   .3 logio PFU Suspension for   Injection (SC/IM) Philippines - English - FDA (Food And Drug Administration)

nobilis® rismavac + ca126 formulation: each dose contains: turkey herpes virus (thv) serotype 3 (fc-126 strain)....... chicken herpes virus (chv) serotype 1 (cvi-988 strain) pfu-plaque forming units processed under fda-2021-001. ..3 logi pfu .3 logio pfu suspension for injection (sc/im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - live turkey herpes virus (thv) , chicken herpes virus (chv) vaccine (vet.) - suspension for injection (sc/im) - formulation: each dose contains: turkey herpes virus (thv) serotype 3 (fc-126 strain)....... chicken herpes virus (chv) serotype 1 (cvi-988 strain) pfu-plaque forming units processed under fda-2021-001. ..3 logi pfu .3 logio pfu

HERPES RELIEF CREAM- roycederm herpes relief cream cream United States - English - NLM (National Library of Medicine)

herpes relief cream- roycederm herpes relief cream cream

ehy holdings llc - graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o) - relief for skin eruptions, itchingin genital area for the treatment ofsymptoms of herpes do not use morethan 3 times daily. children under12 years: ask a docto stop use and ask a doctor if condition worsens or does not improve

VIR COMBINATION (adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum- 2022-2023 liquid United States - English - NLM (National Library of Medicine)

vir combination (adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum- 2022-2023 liquid

deseret biologicals, inc. - human adenovirus e serotype 4 strain cl-68578 antigen (unii: fkd3duk39i) (human adenovirus e serotype 4 strain cl-68578 - unii:fkd3duk39i), human herpesvirus 5 (unii: 7coi029e6k) (human herpesvirus 5 - unii:7coi029e6k), human herpesvirus 1 (unii: 22g38p19rl) (human herpesvirus 1 - unii:22g38p19rl), human herpesvirus 2 (unii: 74j6dnh49u) (human herpesvirus 2 - unii:74j6dnh49u), human herpesvirus 4 (unii: 2a26yw7pnx) (human herpesvirus 4 - unii:2a26yw7pnx), hepatitis b virus (unii: 77h9em77p7) (hepatitis b virus - unii:77h9em77p7), human herpesvirus 6 (unii: 4ix4vp35cr) (human herpesvirus 6 - unii:4ix4vp35cr), influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (uv, formaldehyde inactivated) (unii: 34c49nv47p) (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:ngl844y7x6), influenza a virus a/darwin/9/2021 ivr-228 (h3n2) antigen (uv, formaldehyde inactivated) (unii: p483j7gx6d) (influenza a virus a/darwin/9/2021 ivr-228 (h3n2) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:grn94tp8yv), influenza b virus b/austria/1359417/2021 bvr-26 antigen (uv, formaldehyde inactivated) (unii: tbv2ppg6ef) (influenza b virus b/austria/1359417/2021 bvr-26 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:28eah8253x), influenza b virus b/phuket/3073/2013 antigen (uv, formaldehyde inactivated) (unii: h2198f8zna) (influenza b virus b/phuket/3073/2013 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:3vsf1bf3sr) - adenoviren nosode – cold symptoms, cytomegalovirus nosode - headache, dna - fatigue, muscle aches and pain, epstein-barr virus nosode - fever, hepatitis b nosode – muscle aches and pains, herpes simplex 1 & 2 nosode - rash, human herpesvirus 6a - herpes, human herpesvirus 6b - fatigue, influenzinum – flu symptoms. • for the temporary relief of symptoms including: • cold symptoms  • fever  fatigue  • muscle aches and pains   • headache  • rash  • herpes  • flu symptoms these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds

roche diagnostics australia pty limited - ct749 - herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds - immunoassays for the in vitro qualitative determination of igg class antibodies to hsv-1 and hsv-2 in human serum and plasma. the test are intended for use as an aid in the assessment of immune status and as aid in the diagnosis of hsv infection

Zostavax European Union - English - EMA (European Medicines Agency)

zostavax

merck sharp & dohme b.v. - varicella-zoster virus (live, attenuated) - herpes zoster; immunization - viral vaccines - zostavax is indicated for prevention of herpes zoster ('zoster' or shingles) and herpes-zoster-related post-herpetic neuralgia. zostavax is indicated for immunisation of individuals 50 years of age or older.,

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

roche diagnostics australia pty limited - ct748 - cytomegalovirus (human herpesvirus 5) ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to cytomegalovirus (cmv), also referred to as human herpesvirus 5

Cytomegalovirus (Human herpesvirus 5) IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

cytomegalovirus (human herpesvirus 5) ivds

werfen australia pty ltd - ct748 - cytomegalovirus (human herpesvirus 5) ivds - fully automated chemiluminescent two step immunoassay intended to be used for the quantitative measurement of antibodies in human serum or plasma to provide information about infection with or exposure to cytomegalovirus (cmv), also referred to as human herpesvirus 5.